• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Pathol Lab Med . Comparison of In Situ Hybridization, Immunohistochemistry and Reverse Transcription-Droplet Digital Polymerase Chain Reaction

tetano

Editor, Senior Moderator
Arch Pathol Lab Med


. 2021 Mar 15.
doi: 10.5858/arpa.2021-0008-SA. Online ahead of print.
Comparison of In Situ Hybridization, Immunohistochemistry and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2)-Testing in Tissue


Anja C Roden[SUP] 1 [/SUP], Julie A Vrana[SUP] 1 [/SUP], Justin W Koepplin[SUP] 1 [/SUP], Angela E Hudson[SUP] 1 [/SUP], Andrew P Norgan[SUP] 1 [/SUP], Garrett Jenkinson[SUP] 1 [/SUP], Satoko Yamaoka[SUP] 1 [/SUP], Hideki Ebihara[SUP] 1 [/SUP], Robert Monroe[SUP] 1 [/SUP], Matthias J Szabolcs[SUP] 1 [/SUP], Ramanath Majumdar[SUP] 1 [/SUP], Ann M Moyer[SUP] 1 [/SUP], Joaqu?n J Garc?a[SUP] 1 [/SUP], Benjamin R Kipp[SUP] 1 [/SUP]



Affiliations

Abstract

Context: Small case series have evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-detection in formalin-fixed paraffin-embedded (FFPE) tissue using reverse transcription-polymerase chain reaction (RT-PCR), immunohistochemistry (IHC) and/or RNA-in situ hybridization (RNAish).
Objective: To compare droplet digital PCR (ddPCR), IHC, and RNAish to detect SARS-CoV-2 in FFPE tissue in a large series of lung specimens from coronavirus disease 2019 (COVID-19) patients.
Design: ddPCR and RNAish used commercially available probes; IHC utilized clone 1A9. Twenty-six autopsies of COVID-19 patients with FFPE tissue blocks of 62 lung specimens, 22 heart specimens, 2 brain specimens, and 1 liver, and 1 umbilical cord were included. Control cases included 9 autopsy lungs from patients with other infections/inflammation and virus-infected tissue or cell lines.
Results: ddPCR had the highest sensitivity for SARS-CoV-2 (96%) when compared to IHC (31%) and RNAish (36%). All 3 tests had a specificity of 100%. Agreement between ddPCR and IHC or RNAish was fair (?=0.23, ?=0.35, respectively). Agreement between IHC and ISH was substantial (?=0.75). Interobserver reliability was almost perfect for IHC (?=0.91) and fair to moderate for RNAish (?=0.38-0.59). Lung tissues from patients who died earlier after onset of symptoms revealed higher copy numbers by ddPCR (P=.03, pearson corr = -0.65) and were more likely to be positive by RNAish (P=.02) than lungs from patients who died later. SARS-CoV-2 was identified in hyaline membranes, pneumocytes, and rarely in respiratory epithelium. ddPCR showed low copy numbers in 7 autopsy hearts from ProteoGenex Inc. All other extrapulmonary tissues were negative.
Conclusions: ddPCR was the most sensitive and highly specific test to identify SARS-CoV-2 in lung specimens from COVID-19 patients.
 
Back
Top Bottom